Orgenesis Inc (ORGS) Insider Sells $1,250,000.00 in Stock
Orgenesis Inc (NASDAQ:ORGS) insider Sca Theodorus sold 5,000,000 shares of Orgenesis stock in a transaction on Wednesday, October 11th. The shares were sold at an average price of $0.25, for a total transaction of $1,250,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Orgenesis Inc (ORGS) traded down 3.70% during mid-day trading on Thursday, reaching $0.39. 23,090 shares of the company traded hands. Orgenesis Inc has a 12-month low of $0.28 and a 12-month high of $0.98. The stock’s market capitalization is $47.24 million. The company’s 50-day moving average is $0.40 and its 200-day moving average is $0.56.
TRADEMARK VIOLATION NOTICE: “Orgenesis Inc (ORGS) Insider Sells $1,250,000.00 in Stock” was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/10/12/orgenesis-inc-orgs-insider-sells-1250000-00-in-stock.html.
Orgenesis Company Profile
Orgenesis Inc is a regenerative therapy company. The Company operates through two segments: Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CTB). The CDMO activity is operated by the Company’s subsidiary, MaSTherCell SA, which specializes in cell therapy development for advanced medicinal products.
Receive News & Ratings for Orgenesis Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orgenesis Inc and related companies with MarketBeat.com's FREE daily email newsletter.